Study of Ebola Virus Disease Survivors in Guinea

Clinical Infectious Diseases

Volumn 61, Issue 7, 2015, Pages 1035-1042

  Qureshi, Adnan I ^a,b   Chughtai, Morad ^c   Loua, Tokpagnan Oscar ^a   Pe Kolie, Jean ^d   Camara, Hadja Fatou Sikhe ^a   Ishfaq, Muhammad Fawad ^c   N'Dour, Cheikh Tidane ^e   Beavogui, Kezely ^a,f  

^a Donka National Hospital   (Guinea)

^b ZEENAT QURESHI STROKE INSTITUTE   (United States)

^c SINAI HOSPITAL OF BALTIMORE   (United States)

^d Department of Visceral Surgery China Guinea Friendship Hospital   (Guinea)

^e UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

arthralgia; Ebola virus; Ebola virus disease; Guinea; survivors

Indexed keywords

ABDOMINAL PAIN; ADULT; ANOREXIA; ARTHRALGIA; ARTICLE; BACKACHE; CLINICAL ARTICLE; CONSTIPATION; DIARRHEA; DIZZINESS; EBOLA HEMORRHAGIC FEVER; FEMALE; FUNCTIONAL STATUS; GUINEA; HEADACHE; HEARING IMPAIRMENT; HOSPITAL DISCHARGE; HUMAN; LIBIDO DISORDER; MALE; MYALGIA; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL DYSFUNCTION; SORE THROAT; SURVIVOR; THORAX PAIN; VISUAL IMPAIRMENT; WEIGHT REDUCTION; YOUNG ADULT; ADOLESCENT; EBOLAVIRUS; HEALTH CARE PERSONNEL; HEMORRHAGIC FEVER, EBOLA; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; ARTHRALGIA; EBOLAVIRUS; FEMALE; GUINEA; HEALTH PERSONNEL; HEMORRHAGIC FEVER, EBOLA; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SURVIVORS; YOUNG ADULT;

EID: 84942163638     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ453     Document Type: Article

References (38)

1. World Health Organization. Ebola response roadmap-situation report. Available at: http://www.who.int/csr/disease/ebola/situation-reports/en. Accessed 15 March 2015
2. World Health Organization Ebola Response Team. Ebola virus disease inWest Africa-the first 9 months of the epidemic and forward projections. N Engl J Med 2014; 371:1481-95
3. Qureshi AI, Chughtai M, Bah EI, et al. High survival rates and associated factors among Ebola virus disease patients at Donka National Hospital, Conakry, Guinea. J Vasc Interv Neurol 2015; 8(suppl 1):S4-11
4. Bah EI, Lamah MC, Fletcher T, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med 2015; 372:40-7
5. Schieffelin JS, Shaffer JG, Goba A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 2014; 371:2092-100
6. Qureshi AI, Chughtai M. Acute specialized care of patients with Ebola virus disease: gaps and opportunities. J Vasc Interv Neurol 2015; 8(suppl 1):S1-13
7. Dijkers M. Comparing quantification of pain severity by verbal rating and numeric rating scales. J Spinal Cord Med 2010; 33:232-42
8. Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs 2005; 14:798-804
9. Fichter MM, Quadflieg N. Comparing self-and expert rating: a selfreport screening version (SIAB-S) of the structured interview for anorexic and bulimic syndromes for DSM-IV and ICD-10 (SIAB-EX). Eur Arch Psychiatry Clin Neurosci 2000; 250:175-85
10. Moshirfar M, Fenzl CR, Li Z. What we know about ocular manifestations of Ebola. Clin Ophthalmol 2014; 8:2355-7
11. Kibadi K, Mupapa K, Kuvula K, et al. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis 1999; 179(suppl 1):S13-4
12. Stratford P. Assessing disability and change on individual patients: a report of a patient specific measure. Physiother Can 1995; 47:258-63
13. De Roo A, Ado B, Rose B, Guimard Y, Fonck K, Colebunders R. Survey among survivors of the 1995 Ebola epidemic in Kikwit, Democratic Republic of Congo: their feelings and experiences. Trop Med Int Health 1998; 3:883-5
14. Blair JA, Patzkowski JC, Blanck RV, Owens JG, Hsu JR. Return to duty after integrated orthotic and rehabilitation initiative. J Orthop Trauma 2014; 28:e70-4
15. Drake RE, Frey W, Bond GR, et al. Assisting Social Security Disability Insurance beneficiaries with schizophrenia, bipolar disorder, or major depression in returning to work. Am J Psychiatry 2013; 170:1433-41
16. Stineman MG, Maislin G, Fiedler RC, Granger CV. A prediction model for functional recovery in stroke. Stroke 1997; 28:550-6
17. Lobotesis K, Gholkar A, Jayakrishnan V. Early migration of a self expanding intracranial stent: case report. Neurosurgery 2010; 67:E516-7
18. Forchheimer MB, Richards JS, Chiodo AE, Bryce TN, Dyson-Hudson TA. Cut point determination in the measurement of pain and its relationship to psychosocial and functional measures after traumatic spinal cord injury: a retrospective model spinal cord injury system analysis. Arch Phys Med Rehabil 2011; 92:419-24
19. Hanley MA, Masedo A, Jensen MP, Cardenas D, Turner JA. Pain interference in persons with spinal cord injury: classification of mild, moderate, and severe pain. J Pain 2006; 7:129-33
20. Win MK, Chow A, Dimatatac F, Go CJ, Leo YS. Chikungunya fever in Singapore: acute clinical and laboratory features, and factors associated with persistent arthralgia. J Clin Virol 2010; 49:111-4
21. Pinheiro MB, Ferreira ML, Refshauge K, et al. Genetics and the environment affect the relationship between depression and low back pain: a cotwin control study of Spanish twins. Pain 2015; 156:496-503
22. Paessler S, Walker DH. Pathogenesis of the viral hemorrhagic fevers. Annu Rev Pathol 2013; 8:411-40
23. McElroy AK, Erickson BR, Flietstra TD, et al. Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome. J Infect Dis 2014; 210:558-66
24. Rollin PE, Bausch DG, Sanchez A. Blood chemistry measurements and D-dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis 2007; 196(suppl 2): S364-71
25. Santos E, Boavida JE, Barroso A, Seabra J, Carmona da Mota H. Late osteoarticular lesions following meningococcemia with disseminated intravascular coagulation. Pediatr Radiol 1989; 19:199-202
26. Villinger F, Rollin PE, Brar SS, et al. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis 1999; 179(suppl 1):S188-91
27. Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM. Human fatal Zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis 2010; 4:pii:e837
28. Lorusso L, Mikhaylova SV, Capelli E, Ferrari D, Ngonga GK, Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun Rev 2009; 8:287-91
29. Penttila IA, Harris RJ, Storm P, Haynes D, Worswick DA, Marmion BP. Cytokine dysregulation in the post-Q-fever fatigue syndrome. QJM 1998; 91:549-60
30. Langhans W. Anorexia of infection: current prospects. Nutrition 2000; 16:996-1005
31. Connolly S, Smith DG, Doyle D, Fowler CJ. Chronic fatigue: electromyographic and neuropathological evaluation. J Neurol 1993; 240:435-8
32. Jamal GA, Hansen S. Post-viral fatigue syndrome: evidence for underlying organic disturbance in the muscle fibre. Eur Neurol 1989; 29: 273-6
33. Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol 2011; 11:37
34. Dickinson CJ. Chronic fatigue syndrome-aetiological aspects. Eur J Clin Invest 1997; 27:257-67
35. San Pedro EC, Mountz JM, Liu HG, Deutsch G. Postinfectious cerebellitis: clinical significance of Tc-99m HMPAO brain SPECT compared with MRI. Clin Nucl Med 1998; 23:212-6
36. Bwaka MA, Bonnet MJ, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 1999; 179(suppl 1):S1-7
37. Khan AS, Tshioko FK, Heymann DL, et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 1999; 179(suppl 1): S76-86
38. Jette AM. Functional Status Index: reliability of a chronic disease evaluation instrument. Arch Phys Med Rehabil 1980; 61:395-401